权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer

增强现实平台可减少儿科癌症术后和长期阿片类药物的使用

基本信息

批准号：
10471451
负责人：
Juan Pablo Cata
金额：
$ 91.29万
依托单位：
ALTALITY, INC.
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-06-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10471451
关键词：
3-Dimensional Acute Adult Analgesics Augmented Reality Beds Cancer Center Cancer Patient Caregivers Cessation of life Child Childhood Chronic Clinical Clinical Trials Collaborations Collection Control Groups Critical Illness Critically ill children Data Data Analyses Dependence Device Approval Devices Diagnosis Disease Dose Effectiveness Family Feasibility Studies Feedback Future Goals Grant Helping to End Addiction Long-term Hospitalization Hospitals Human Resources Hyperalgesia Immunocompromised Host Inpatients Institutional Review Boards Intractable Pain Journals Legal patent Life Malignant Childhood Neoplasm Malignant Neoplasms Manuscripts Medical Device Medicine Movement Operative Surgical Procedures Opiate Addiction Opioid Outcome Outpatients Pain Pain management Patients Pediatric Hospitals Pediatric Oncologist Pediatric Oncology Pediatric cohort Peer Review Perioperative Persons Pharmaceutical Preparations Phase Phase II Clinical Trials Population Postoperative Pain Postoperative Period Procedures Protocols documentation Public Health Randomized Controlled Clinical Trials Randomized Controlled Trials Reporting Research Risk Sickle Cell Anemia Site Small Business Technology Transfer Research Source Specialist Substance abuse problem Surgical Oncology Surveys Survival Rate Survivors Texas Time Toxic effect Training Trauma United States National Institutes of Health academic review base childhood cancer survivor clinical pain cognitive modulation of pain college commercial application cost cost effective design disease transmission distraction efficacy evaluation experience feasibility testing handheld mobile device health care settings high risk high risk population long-term sequelae mobile application morphine equivalent non-opioid analgesic nonmedical use opioid abuse prevention opioid use pain reduction patient population pediatric patients phase 2 study prescription opioid prevent satisfaction tool usability virtual reality headset ward

项目摘要

PROJECT SUMMARY/ABSTRACT Pediatric opioid use is a public health crisis. In children, prescription opioids are the primary source of non- medical abuse as well as opioid-associated hospitalizations and deaths. Early opioid use in childhood is a known “gateway” to adulthood dependence and substance abuse disorders. Despite years of research, opioids remain the most commonly prescribed pain medication for children with cancer. These children experience pain from the time of diagnosis into adulthood as survivors, primarily from the treatment for their cancer. The majority of pediatric cancer patients have persistent opioid use in the months following major surgery to cure or to treat their disease. More concerning, studies in childhood cancer survivors show that major surgery increases risk of new-onset and chronic opioid use. The high costs and lack of scalability of traditional distraction-based medical devices for managing pain, such as virtual reality headsets, limit their clinical impact and commercial potential. As cancer patients are often immunocompromised, risk from infectious disease transmission from sharing devices is an additional, possibly life-threatening, concern. Mobile augmented reality applications eliminate these limitations, representing a cost-effective, safe and commercially viable adjunctive tool for pain management in critically ill children. Our goal is to reduce long-term opioid use in children with cancer undergoing major surgery by distracting them from their pain with a scavenger hunt-style mobile AR game while they are recovering in the hospital. To achieve this goal, we have collaborated with pediatric oncologists, anesthesiologists and pain specialists at the MD Anderson Cancer Center and the Baylor College of Medicine (Texas Children’s Hospital). In Phase I, we will demonstrate the feasibility of investigating the ARISE (Augmented Reality Incorporating Spatial Enhancement) game for reducing opioid consumption in the inpatient postoperative wards. In Phase II, we will evaluate the efficacy of the game to reduce immediate and long-term postoperative opioid use in children with cancer undergoing major treatment-related surgery in a multi-site randomized controlled clinical trial (AURORA trial: Augmented Reality for Opioid Reduction in Childhood Cancer). To our knowledge, this is the first RCT to investigate mobile augmented reality for opioid reduction in pediatric cancer patients or for postoperative opioid reduction in any pediatric population. As the majority of children with cancer are expected to survive long-term, the benefits of reducing and preventing chronic opioid use in this high-risk, refractory pain population will last over the lifetime of a child.

项目总结/文摘